InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Bersani Pietro. Officer active across 1 company, notably Kiromic Biopharma, Inc.. Aggregated, 4 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €14k. Activity tracked since 11 August 2022. The latest transaction was filed on 23 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant with 4 filings in total. In the 4 most recent filings we hold, all concern Kiromic Biopharma, Inc. on XNAS, where the listed role is Chief Executive Officer, with acquisitions from 2022-08-15 to 2024-08-26 and total purchases of EUR 13969, with no reported sales.